RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Stemline Therapeutics Stock and on which exchange is it traded?
The symbol for Stemline Therapeutics is STML and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Stemline Therapeutics Stock?
Stemline Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Stemline Therapeutics Stock?
Stemline Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Stemline Therapeutics Stock.

What's the current price of Stemline Therapeutics Stock?
As of the end of day on the 2020-09-04, the price of an Stemline Therapeutics (STML) share was $11.83.

What is the 52-week high and low for Stemline Therapeutics Stock?
The 52-week high for Stemline Therapeutics Stock is $12.35 and the 52-week low is $3.21.
Click to get the best stock tips daily for free!

About Stemline Therapeutics

Stemline Therapeutics Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary oncology therapeutics in the United States. It develops SL-401, a targeted therapy directed to the interleukin-3 receptor (IL-3R), which is in Phase II clinical trial for advanced hematologic cancers; SL-701, an immunotherapy to attack tumors that is in Phase II clinical trial; and SL-80... STML Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT